Portfolio company
Miracor Medical SA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a pressure-controlled intermittent coronary sinus occlusion system to treat patients with impaired cardiac function and heart attacks.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CorFlow Therapeutics
This medical device company develops a platform to diagnose and treat microvascular obstruction in heart attack patients for interventional cardiologists.
CorFlow Therapeutics AG
This company develops medical devices for diagnosing and treating microvascular obstruction in heart attack patients for use by interventional cardiologists in catheterisation laboratories.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
Meacor
Meacor develops a catheter-based medical device for repairing heart valves to treat patients with mitral and tricuspid regurgitation without undergoing open-heart surgery.
Corvia Medical
This company develops an atrial shunt to treat patients suffering from heart failure with preserved or mildly reduced ejection fraction.
CorInnova
The company develops a minimally invasive cardiac assist device to treat patients with acute heart failure without contacting the blood.
AtaCor Medical
This company develops extravascular defibrillation leads and deployment systems for cardiac patients to manage heart rhythms without entering the vascular system.
Echopoint Medical
The company develops a microcatheter system for cardiologists to diagnose coronary heart conditions and measure physiology within clinical settings.
